Global Oral Antibiotics Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

Oral antibiotics market is moving towards more targeted and personalized treatment regimens, aided by advances in microbiome research and diagnostic technologies

• Oral antibiotics are medications taken by mouth to treat bacterial infections. They are available in various forms such as tablets, capsules, or liquids. Common examples include penicillin, amoxicillin, ciprofloxacin, and azithromycin. These antibiotics kill or inhibit the growth of bacteria in the body.
• Antibiotic usage has increased in developing countries due to factors such as improved healthcare infrastructure, population expansion, and more access to medical facilities. As these countries expand economically and urbanize, the demand for oral antibiotics rises. The need to manage infectious diseases and promote public health is driving this rise, resulting in a larger market for oral antibiotics in these regions.
• The rise in the global prevalence of infectious disorders such as respiratory tract infections, urinary tract infections, and skin infections has aided the expansion of the oral antibiotics market. Infectious diseases have proliferated due to factors such as population density, insufficient sanitation, and increasing medicine resistance. Oral antibiotics provide a convenient and efficient treatment option for a wide range of these infections, fueling market demand for these drugs.
• With the rise of antibiotic-resistant bacteria, there is an urgent need to develop improved medicines to combat these strains. This is a large market opportunity for oral antibiotics. Developing new antibiotic classes or modifying existing ones to improve efficacy against resistant bacteria can stimulate demand for these drugs. Combination medicines, tailored drug delivery systems, and alternative treatment choices are examples of possible growth opportunities for the oral antibiotics industry.
• Continuous R&D efforts in oral antibiotics present an interesting market opportunity. New ways to fight infections and overcome antibiotic resistance, such as phage treatment, antimicrobial peptides, and immune modulators, offer promise. These novel techniques give alternatives or adjuvants to standard oral antibiotics, broadening the therapeutic options available to physicians. Innovative medicines address unmet medical requirements and open up new opportunities for growth and commercial expansion in the oral antibiotics sector.
• However, the extended time required for approval is one market limitation for the oral antibiotics business. The regulatory approval procedure for novel antibiotics can be time-consuming and labor-intensive, involving significant clinical trials and safety reviews. This may cause a delay in the market availability of new oral antibiotics.
• The emergence of antibiotic resistance is a key market challenge for the oral antibiotics business. Antibiotic abuse and misuse contribute to the creation of resistant bacteria, lowering the efficiency of conventional antibiotics and necessitating the development of new therapeutic techniques.

Market Segmentations

• The Global Oral Antibiotics Market is segmented based on Class, Action Mechanism, Application, Drug Origin, Activity Spectrum, Drug Type, and Geography.
• By Class, the Global Oral Antibiotics Market is classified into Beta-Lactam and Beta Lactamase Inhibitors (Penicillin, Cephalosporin, Others), Quinolones, Macrolides, and Others.
• Beta Lactam and Beta-Lactamase Inhibitors (Penicillin, Cephalosporin, and Others) hold a larger market share. This is due to their broad spectrum of activity, well-established efficacy, and diverse applications in treating various bacterial illnesses.
• By Action Mechanism, the Global Oral Antibiotics Market is classified into Cell Wall Synthesis Inhibitors, Mycolic Acid Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors, Protein Synthesis Inhibitors, and Other Mechanisms.
• Cell Wall Synthesis Inhibitors hold a significant market share. This is due to the fact that medications in this class, such as Beta Lactam antibiotics (Penicillin, Cephalosporin), are widely utilized due to their efficiency in targeting and destroying the bacterial cell wall, making them effective against a wide spectrum of bacterial infections.
• By Application, the Global Oral Antibiotics Market is classified into Community-Acquired Respiratory Tract Infections (CARTIs), Urinary Tract Infections (UTIs), and Others.
• Community-Acquired Respiratory Tract Infections (CARTIs) hold a larger market share. This is due to the high prevalence of respiratory tract infections in the community, such as pneumonia, bronchitis, and sinusitis, which frequently necessitate the use of oral antibiotics for efficient treatment and management.
• By Drug Origin, the Global Oral Antibiotics Market is classified into Natural, Semisynthetic, and Synthetic.
• Semisynthetic antibiotics hold a significant market share. Semisynthetic antibiotics are generated from natural sources but chemically changed to improve potency, stability, or activity spectrum. Amoxicillin, ampicillin, and oxacillin are examples of commonly used antibiotics in this category.
• By Activity Spectrum, the Global Oral Antibiotics Market is classified into Broad-spectrum antibiotics and Mid/Narrow-spectrum antibiotic.
• Broad-spectrum antibiotics hold a larger market share. They work against a wide variety of bacteria, including Gram-positive and Gram-negative types. Because of their greater activity spectrum, they are adaptable and frequently favored in clinical use, as they may treat a wide range of infections without requiring exact bacterial identification.
• By Drug Type, the Global Oral Antibiotics Market is classified into Branded and Generics.
• Generics hold a significant market share. When a branded antibiotic's patent expires, generic alternatives with the same active component become cheaper. The affordability of generic antibiotics and equivalent efficacy boosts their market share.
• By Geography, the Global Oral Antibiotics Market is classified into the Americas, Europe, Middle-East & Africa, and Asia-Pacific.
• The Americas have a larger market share in the oral antibiotics market. This is due to factors such as high healthcare expenditure, modern healthcare infrastructure, and a considerable burden of infectious diseases, resulting in a greater demand for oral antibiotics in the region.

Recent Development

• AstraZeneca signs $2 billion agreement with Quell to develop cell therapies - June 2023
• Gilead Sciences Completes Acquisition of MiroBio - September 2022

Company Profiles

Countries Studied

• America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
• Europe (Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Luxemburg, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
• Middle-East and Africa (Egypt, Israel, Qatar, Nigeria, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
• Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

Ansoff Analysis

• The report presents a detailed Ansoff matrix analysis for the Global Oral Antibiotics Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development, and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
• The publisher analyses the Global Oral Antibiotics Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
• Based on the SWOT analysis conducted on the industry and industry players, the publisher has devised suitable strategies for market growth.

Why buy this report?

• The report offers a comprehensive evaluation of the Global Oral Antibiotics Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
• The research report also provides a detailed market size analysis and projections in volume and value terms. The projections are calculated using verified research methodologies.
• Excel data sheet for the market size will also be provided with the report.
• The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
• The report includes an in-depth market analysis using Porter’s 5 forces model, PESTLE Analysis, and the Ansoff Matrix. In addition, the impact of COVID-19 on the market is also featured in the report.
• The report includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
• The report includes Self-Assessment Form, which helps customers evaluate their position in the market compared to their competitors
• The report offers customized research - tailored uniquely to our customers with a quick turnaround time. We offer a 15% customization option at no extra charge to all our clients for any of our syndicated reports.

Report Highlights:

• A complete analysis of the market, including the parent industry
• Important market dynamics and trends
• Impact Analysis - a comprehensive assessment to confront risk and make strategic & operational decisions to counter the changes in the market environment.
• Market segmentation
• Competitive Analysis: Comparative analysis of competitor
• Historical, current, and projected size of the market based on value and volume
• Market size of the US states
• Market shares and strategies of key players
• Recommendations to companies for strengthening their foothold in the market